A NEW HOPE FOR BODY CONTROL ?

Researchers are rapidly focused on retatrutide, a promising drug developed by Eli Lilly, as a possible breakthrough in weight loss . Different than many existing approaches, retatrutide is a dual -action agonist targeting simultaneously GLP-1 and GIP, hormones that impact hunger and glucose balan